title: "Pseudocavitation" in thymic carcinoma during treatment with sunitinib.
authors.affiliation: Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: Marcello
authors.initials: M
authors.lastname: Tiseo
authors.forename: Arun
authors.initials: A
authors.lastname: Rajan
authors.forename: Anish
authors.initials: A
authors.lastname: Thomas
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Giaccone
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D017322:Clinical Trials, Phase II as Topic; D006333:Heart Failure / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib